Nr

Sex/agea

Typeb

TNM

Rh-TSHc

TSHd

Tge

I-124 PET/CTf

Posttx I-131 WBSg

Other imagingh

Comment/validation

1

F/21

Pap

T4N1M1

y

>100

66

TP (lung)

+(200 mCi)

CT+

Lung metastases on CT

2

M/29

Pap

T1/2N0M0

y

>100

0.3

TP

n/a

CT/MRI−

I-124 + lesion skull, earlier post-ablation I-131 + (100 mCi), normal CT and MRI.

No substrate on CT/MRI

3

F/44

Pap

T1N0M0

y

>100

<0.2

FP

n/a

CT−

Cricoid activity, no substrate on CT

4

M/60

Pap

T3N1M0

y

89

36

FN

+(200 mCi)

FDG+

Lymph nodes mediastinum

M/61

Pap

T3N1M0

n

69

71

FN

+(200 mCi)

FDG+

Lymph nodes mediastinum

5

F/17

Pap

T4N1M0

n

>100

1182

FN

+(150 mCi)

FDG+

Lymph nodes neck

6

M/42

Pap

T4N1M0

y

68

279

FN

+(200 mCi)

FDG+

Lymph nodes neck

7

F/57

Fol

T3N0M1

y

49

4706

FN

+(200 mCi)

FDG+

Multiple bone metastases

8

M/35

Pap

T?N1M0

y

72

28

FN/TN*

−(150 mCi)

n/a

*I-124 was false negative based on Tg, but was concordant with post therapy I-131 WBS

M/46

Pap

T?N1M0

n

82

14

FN

n/a

US neck−

Based on elevated Tg, now watchful waiting

9

M/61

Hür

T4N?M0

y

73

1387

FN

n/a

Octreoscan+, CT−

Lung/lymph node metastases I-131 negative. Earlier post therapy I-131 negative.

10

F/71

Pap + Fol

T2N0M1

y

>100

3

TN

n/a

n/a

F/72

Pap + Fol

T2N0M1

y

>100

5

FN

n/a

FDG−

Initially lung metastases. Recurrence based on elevated Tg. Watchful waiting.

11

F/31

Pap

T3N1M0

y

>100

38

FN

n/a

FDG+

Lymph nodes neck/mediastinum. Surgery

12

F/22

Pap

T2N1M0

y

47

6

FN

n/a

US neck−

Based on elevated Tg, watchful waiting

13

M/44

Pap

T?N1M0

y

64

11

FN

n/a

US neck−

Based on elevated Tg, watchful waiting

14

F/56

Fol

T2N0M0

y

>100

*anti-Tg 165

TN

n/a

FDG−

Stimulated Tg and Anti-Tg negative on follow up 1 year later with normal FDG/i-124 PET

15

F/63

Pap

T?N1M0

y

>100

*anti-Tg 219

TN

n/a

FDG+ (FP)

FDG avid lesion not found in surgery. Anti-Tg positive

F/65

Pap

T?N1M0

y

>100

*anti-Tg 164

TN

n/a

n/a

I-124 considered TN because of lowered anti-Tg

16

F/33

Pap + Fol

T2N0M0

y

94

<0.2

TN

n/a

n/a

17

F/51

Fol

T1N?M?

y

95

0.4

TN

n/a

n/a

18

F/63

Pap

T?N1M0

y

>100

0.4

TN

n/a

FDG−

19

F/60

Fol − Hür

T2N0M0

y

>100

<0.2

TN

n/a

US neck−

20

F/39

Pap

T4N1M0

y

90

<0.2

TN

n/a

US nec−

21

F/67

Pap

T2N0M0

y

>100

<0.2

TN

n/a

US neck−